UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Pfizer Vaccine ‘Safe and Protective’ for Adolescents – Early Data Release 31/03/2021 Chandre Prince The Pfizer-BioNTech COVID-19 vaccine is safe and protective in children as young as 12 with no serious side effects in adolescents who received the vaccination, the company said on Wednesday. Interim results of a recent clinical trial of some 2,260 adolescents ages 12-15 years old was published by the pharma company – although it has […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Pfizer Vaccine ‘Safe and Protective’ for Adolescents – Early Data Release 31/03/2021 Chandre Prince The Pfizer-BioNTech COVID-19 vaccine is safe and protective in children as young as 12 with no serious side effects in adolescents who received the vaccination, the company said on Wednesday. Interim results of a recent clinical trial of some 2,260 adolescents ages 12-15 years old was published by the pharma company – although it has […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Pfizer Vaccine ‘Safe and Protective’ for Adolescents – Early Data Release 31/03/2021 Chandre Prince The Pfizer-BioNTech COVID-19 vaccine is safe and protective in children as young as 12 with no serious side effects in adolescents who received the vaccination, the company said on Wednesday. Interim results of a recent clinical trial of some 2,260 adolescents ages 12-15 years old was published by the pharma company – although it has […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Pfizer Vaccine ‘Safe and Protective’ for Adolescents – Early Data Release 31/03/2021 Chandre Prince The Pfizer-BioNTech COVID-19 vaccine is safe and protective in children as young as 12 with no serious side effects in adolescents who received the vaccination, the company said on Wednesday. Interim results of a recent clinical trial of some 2,260 adolescents ages 12-15 years old was published by the pharma company – although it has […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Pfizer Vaccine ‘Safe and Protective’ for Adolescents – Early Data Release 31/03/2021 Chandre Prince The Pfizer-BioNTech COVID-19 vaccine is safe and protective in children as young as 12 with no serious side effects in adolescents who received the vaccination, the company said on Wednesday. Interim results of a recent clinical trial of some 2,260 adolescents ages 12-15 years old was published by the pharma company – although it has […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer Vaccine ‘Safe and Protective’ for Adolescents – Early Data Release 31/03/2021 Chandre Prince The Pfizer-BioNTech COVID-19 vaccine is safe and protective in children as young as 12 with no serious side effects in adolescents who received the vaccination, the company said on Wednesday. Interim results of a recent clinical trial of some 2,260 adolescents ages 12-15 years old was published by the pharma company – although it has […] Continue reading -> Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
Europe Faces Third Wave Of COVID, Potentially Worse Than Previous Surges Due To Variants 29/03/2021 Madeleine Hoecklin European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading -> New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts
Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> Posts navigation Older postsNewer posts